Possible sites at which 5-hydroxytryptamine may antagonize in vivo neuromuscular paralysis.
D000818:Animals; D000992:Antitoxins / Q000494:pharmacology; D001665:Binding Sites; D001905:Botulinum Toxins / Q000037:antagonists & inhibitors; D003014:Clostridium botulinum; D006426:Hemicholinium 3 / Q000037:antagonists & inhibitors; D007099:Imipramine / Q000008:administration & dosage; D007211:Indoles / Q000037:antagonists & inhibitors; D007274:Injections, Intraperitoneal; D008566:Membranes; D051379:Mice; D009469:Neuromuscular Junction / Q000187:drug effects*; D051381:Rats; D012701:Serotonin / Q000097:blood / Q000494:pharmacology*; D014403:Tubocurarine / Q000037:antagonists & inhibitors
D000992:Antitoxins; D007211:Indoles; D006426:Hemicholinium 3; D012701:Serotonin; D001905:Botulinum Toxins; D007099:Imipramine; D014403:Tubocurarine